AGAPE ATP CORPORATION Payments of Debt Issuance Costs
AGAPE ATP CORPORATION (ATPC) reported Payments of Debt Issuance Costs of $113.91 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2024-11-14
- AGAPE ATP CORPORATION payments of debt issuance costs for the quarter ending 2023-09-30 was $91.05K, a 1543.50% increase year-over-year.
- AGAPE ATP CORPORATION payments of debt issuance costs for the quarter ending 2023-06-30 was $15.90K.
- AGAPE ATP CORPORATION payments of debt issuance costs for the quarter ending 2023-03-31 was $6.96K.
- AGAPE ATP CORPORATION payments of debt issuance costs for the quarter ending 2022-12-31 was $50.00K.
- AGAPE ATP CORPORATION payments of debt issuance costs for fiscal 2022 was $234.47K, a 1441.53% increase from fiscal 2021.
- AGAPE ATP CORPORATION payments of debt issuance costs for fiscal 2021 was $15.21K, a 93.90% decline from fiscal 2020.
- AGAPE ATP CORPORATION payments of debt issuance costs for fiscal 2020 was $249.53K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-09-30 | $91.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $106.95K derived: sum of 2 quarters · filed 2024-11-14 | $113.91K 10-Q · filed 2024-11-14 | $163.91K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $15.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $22.86K 10-Q · filed 2024-08-14 | $72.86K derived: sum of 3 quarters · filed 2024-08-14 | $78.40K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $6.96K 10-Q · filed 2024-05-14 | $56.96K derived: sum of 2 quarters · filed 2024-05-14 | $62.50K derived: sum of 3 quarters · filed 2024-05-14 | |
| 2022-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $55.54K derived: sum of 2 quarters · filed 2024-04-01 | $234.47K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $5.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $184.47K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $178.93K 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.05K derived: sum of 2 quarters · filed 2023-03-31 | $8.79K derived: sum of 3 quarters · filed 2023-03-31 | $15.21K 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $8.79K derived: sum of 2 quarters · filed 2022-11-14 | $15.21K 10-Q · filed 2022-11-14 | $61.50K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $7.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $14.16K 10-Q · filed 2022-08-11 | $60.45K derived: sum of 3 quarters · filed 2022-08-11 | $187.95K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $6.42K 10-Q · filed 2022-05-13 | $52.71K derived: sum of 2 quarters · filed 2022-07-05 | $180.21K derived: sum of 3 quarters · filed 2022-07-05 | |
| 2020-12-31 | $46.29K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $173.79K derived: sum of 2 quarters · filed 2022-07-05 | $249.53K 10-K/A · filed 2022-07-05 | |
| 2020-09-30 | $127.50K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | $203.24K 10-Q/A · filed 2022-07-05 | ||
| 2020-06-30 | $75.74K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |